LIVE
LIVE GMP
Shellz India Ltd₹+13·Tonbo Imaging India Ltd₹+495·Zetwerk Manufacturing Business Ltd₹+11·Bonfiglioli Transmissions Ltd₹+138·Sahajanand Medical Technologies Ltd₹+42·Ravita Engineering Services Ltd₹+3·Fusion CX Ltd₹+20·Jio Platforms Ltd₹+222·Paras Healthcare Ltd₹+90·HD Fire Protect Ltd₹+80·Vaibhav Vyapaar Ltd₹0·R.K.Fashion Accessories Ltd₹0·Vishal Nirmiti Ltd₹+8·Nityas Gems & Jewellery Ltd₹+1·Paramount Syntex Ltd₹0·Acme India Industries Ltd₹+47·TNA Solutions Ltd₹+10·Dove Soft Ltd₹0·Omara Ventures India Ltd₹0·Shellz India Ltd₹+13·Tonbo Imaging India Ltd₹+495·Zetwerk Manufacturing Business Ltd₹+11·Bonfiglioli Transmissions Ltd₹+138·Sahajanand Medical Technologies Ltd₹+42·Ravita Engineering Services Ltd₹+3·Fusion CX Ltd₹+20·Jio Platforms Ltd₹+222·Paras Healthcare Ltd₹+90·HD Fire Protect Ltd₹+80·Vaibhav Vyapaar Ltd₹0·R.K.Fashion Accessories Ltd₹0·Vishal Nirmiti Ltd₹+8·Nityas Gems & Jewellery Ltd₹+1·Paramount Syntex Ltd₹0·Acme India Industries Ltd₹+47·TNA Solutions Ltd₹+10·Dove Soft Ltd₹0·Omara Ventures India Ltd₹0·
Aureate Tradde Ltd
CLOSED
BSE SME
Fixed Price IPO
Fresh capital only
Aureate Tradde IPO GMP
GREY MARKET
PREMIUM
₹
+ 2
+3% expected return
EST. LISTING
PRICE
₹72
Issue Price: ₹
70
Issue Price
₹70
Face Value
₹10
Lot Size
2,000 shares
Open Date
29 May 2026
Close Date
02 Jun 2026
Allotment
03 Jun 2026
Listing Date
05 Jun 2026
Exchange
BSE SME
Aureate Tradde IPO Details: Price, Dates & Financials
The Aureate Tradde IPO GMP strength score is 5.6 out of 10, which the dashboard rates as Moderate. The Aureate Tradde IPO valuation is tagged Good. The Aureate Tradde IPO is subscribed 1.43 times overall so far. Amounts are calculated at the upper price band of ₹70.
IPO Analytics Dashboard
LIVE
Aureate Tradde IPO GMP Insights
Valuation
Good
Aureate Tradde IPO GMP Strength Score
6
/ 10
Moderate
0–3 Weak
3–6 Moderate
6–8 Good
8–10 Strong
Aureate Tradde IPO Category-wise Subscription
Shares offered, bid & amount
| Category | Sub (x) | Offered | Bid For |
|---|---|---|---|
| NII / HNI | 0.45 | 1,850,000 | 830,000 |
| Retail (RII) | 2.42 | 1,852,000 | 4,476,000 |
| Market Maker | — | 196,000 | — |
| Total | 1.43 | 3,702,000 | 5,306,000 |
* Amount calculated at upper price band (₹70) · ** Total includes all investor categories
Aureate Tradde IPO Application Sizing
Minimum investment by category
Retail Investors ?
Min. Lots
2
Shares / Lot
4,000
Min. Investment
₹280,000
HNI Investors ?
Min. Lots
3
Min. Shares
6,000
Min. Investment
₹420,000
Aureate Tradde IPO Valuation — EPS & P/E
Pre & post-issue metrics
Pre-Issue EPS ?
₹ 3
Post-Issue EPS ?
₹ 4
Pre-Issue P/E ?
25 x
Post-Issue P/E ?
16 x
Aureate Tradde IPO Timeline & Key Dates
- 1 Initiation of Refund 04 Jun 2026
- 2 Credit of Shares to Demat 04 Jun 2026
Investor Interpretation
- The IPO P/E of 16x reflects a good valuation relative to typical market ranges.
- Pre-issue EPS of ₹3 compares to post-issue EPS of ₹4 after dilution.
This IPO has relatively lower interest or stretched valuation. Proceed with thorough research and caution.
Aureate Tradde IPO Subscription FAQs
Aureate Tradde IPO is subscribed 1.43x overall (Retail 2.42x, NII/HNI 0.45x).
The retail (RII) portion of Aureate Tradde IPO is subscribed 2.42x.
Aureate Tradde IPO — NII/HNI 0.45x.
In Aureate Tradde IPO, retail investors can apply for a minimum of 2 lot(s) (₹₹280,000); HNI/sNII minimum 3 lots (₹₹420,000).
Shares offered by category — Retail 1,852,000 shares.
Aureate Tradde IPO valuation — pre-issue EPS ₹2.83, post-issue EPS ₹4.47, pre-issue P/E 24.71, post-issue P/E 15.64.
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.
The NII category covers investors applying for shares outside the retail investor category, while HNI commonly refers to high-value investors within the NII category. Understanding the Aureate Tradde IPO's NII and HNI subscription levels helps investors assess demand for the Aureate Tradde IPO and overall investor interest.
GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.